We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Codon Devices Opens European Headquarters

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Codon Devices Opens European Headquarters"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Codon Devices, Inc., the Constructive Biology Company™, today announced its expansion into Europe with the formation of Codon Devices U.K. Ltd., and the appointment of Michael Dyson, PhD, to the newly-created position of European Managing Director.

“We are excited to open our new European headquarters as a major step in our global expansion plans,” said John P. Danner, President and Chief Executive Officer of Codon Devices.

“As we industrialize synthetic biology and drive a new paradigm in research called Constructive Biology™, we are experiencing rapid adoption of our advanced gene synthesis and protein engineering offerings.  The interest from the European marketplace is tremendous and we are looking forward to serving these customers more effectively through this new base of operations.”

Michael Dyson will lead Codon Devices U.K., Ltd., reporting to Michael J. Fitzpatrick, Vice President, Global Sales, Codon Devices, Inc. Dr. Dyson has more than 20 years of experience leading European customer service and sales organizations in the life sciences industry.  Prior to joining Codon Devices, Dr. Dyson was Managing Director for Sequenom, GmbH and Director, European Sales and Marketing for MicroCal, LLC.

“Mike brings exceptional leadership capability and in-depth knowledge of the European market,” said Michael Fitzpatrick. “His proven track record of building successful operations to drive growth and customer satisfaction make him a valuable addition to our team.”

“Codon Devices has established strong relationships with many European pharmaceutical, biotechnology and agribusiness-focused companies, as well as renowned centers of academic research,” said Michael Dyson. “I am excited to build upon Codon’s strong position in the market through this new headquarters and the rapid installation of direct sales operations throughout Europe.”